CRNX - Crinetics Pharmaceuticals GAAP EPS of -$0.94 revenue of $1M August, 08 2023 08:00 AM Crinetics Pharmaceuticals Inc. 2023-08-08 08:00:55 ET Crinetics Pharmaceuticals press release ( NASDAQ: CRNX ): Q2 GAAP EPS of -$0.94. Revenue of $1M (+150.0% Y/Y). For further details see: Crinetics Pharmaceuticals GAAP EPS of -$0.94, revenue of $1M